PROTEROS BIOSTRUCTURES GmbH

PROTEROS BIOSTRUCTURES GmbH is a company in Martinsried, Germany that has taken part in 2 EU-funded projects since 2009, receiving €1.1M in EU funding.

EU funding received€1.1M
EU projects2
As coordinator0
Running now0
First EU project2009
Latest project2012
CountryGermany
EU registration (PIC)996481680
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are PROTEROS BIOSTRUCTURES GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.1M · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • EUTRAINPartner

    EUropean TRanslational training for Autoimmunity & Immune manipulation Network

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €240ktheir share
  • ANTIPATHOGNPartner

    Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €849ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • bacteriology
  • clinical microbiology
  • drug discovery
  • drug resistance
  • inflammatory diseases
  • rheumatology
  • social inequalities
  • structural biology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime